These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 29718867)
1. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis. Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis. Lv XH; Wang CH; Xie Y J Gastroenterol Hepatol; 2017 Sep; 32(9):1540-1547. PubMed ID: 28299819 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial. Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG J Cancer Res Clin Oncol; 2015 Jun; 141(6):1103-8. PubMed ID: 25504506 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis. Feng J; Zhao Y; Zhai L; Zhou J Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263 [TBL] [Abstract][Full Text] [Related]
5. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis. Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958 [TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis. Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis. Wei Y; Liu J; Yan M; Zhao S; Long Y; Zhang W Chemotherapy; 2019; 64(2):94-104. PubMed ID: 31569090 [TBL] [Abstract][Full Text] [Related]
8. A Meta-Analysis of Arsenic Trioxide Combined with Transcatheter Arterial Chemoembolization for Treatment of Primary Hepatic Carcinoma. He L; Xu Q; Chen L; Chen R Evid Based Complement Alternat Med; 2016; 2016():3428370. PubMed ID: 27382405 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Huo YR; Eslick GD JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200 [TBL] [Abstract][Full Text] [Related]
10. Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population. Jia S; Fu Y; Tao H Pharm Biol; 2020 Dec; 58(1):771-784. PubMed ID: 32767901 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter Arterial Chemoembolization Plus Zhu ZX; Liao MH; Wang XX; Huang JW Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the efficacy and safety of iodine [ Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis. Ji J; Zhang Z; Hou Z; Qiu G; Mi S; Jin Z; Huang J Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102313. PubMed ID: 38453011 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis. Chen A; Li S; Yao Z; Hu J; Cao J; Topatana W; Juengpanich S; Yu H; Shen J; Chen M J Gastroenterol Hepatol; 2021 Feb; 36(2):302-310. PubMed ID: 32652685 [TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma. Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383 [TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis. Li L; Tian J; Liu P; Wang X; Zhu Z Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950 [TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis. Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]